Annual Congress Vienna 2009

Saturday, 12.09.2009
Sunday, 13.09.2009
Monday, 14.09.2009
Tuesday, 15.09.2009
Wednesday, 16.09.2009

Citations should be made in the following way: Authors. Title. Eur Respir J 2009; 34: Suppl. 53, abstract number.

Material from 2009:

4047 Abstracts
652 Slide presentations
300 Webcasts
93 Handouts
2150 e-posters
300 Multimedia files

Material from 2009: Show

Diagnosis and treatment of lung cancer

Oral Presentation
Chairs: J-P. Sculier (Brussels, Belgium), N. Schoenfeld (Berlin, Germany)

Download all media

Routine analysis of diagnostic, prognostic and predictive cancer markers from transbronchial (TBna) cytology needle aspiration samples R. Yung, O. Abdelrehim, K. Li, P. Illei (Baltimore, United States Of America)
The relation of fluorine-18 fluorodeoxyglucose positron emission tomography imaging to chemosensitivity for platinum doublet chemotherapy in patients with advanced stage non small cell lung cancer N. Kobayashi, Y. Watanuki, N. Miyazawa, S. Inoue, M. Kudo, T. Sato, K. Mishina, T. Kaneko, Y. Ishigatsubo (Yokohama, Japan)
Mesenchymal stem cells reduce lung metastases by controlled targeted delivery of TNF-related apoptosis-inducing ligand (TRAIL) M. R. Loebinger, S. M. Janes (London, United Kingdom)
Combined endoesophageal-endobronchial ultrasound-guided, fine-needle aspiration of mediastinal lymph nodes through a single bronchoscope in 150 patients with suspected lung cancer F. J. F. Herth, A. Ernst, M. Krasnik, R. Eberhardt (Heidelberg, Germany; Boston, United States Of America; Copenhagen, Denmark)
Shox2, a biomarker for confirming malignancy in bronchial lavage from patients with suspected lung cancer and inconclusive cytology B. Schmidt, V. Liebenberg, D. Dietrich, C. Kneip, T. Schlegel, S. Weickmann, A. Seegebarth, C. Witt, M. Fleischhacker, T. Liloglou, O. Raji, J. K. Field (Berlin, Germany; Liverpool, United Kingdom)
Prior noninvasive ventilation is a bad prognostic factor in mechanically ventilated cancer patients A. P. Meert, T. Berghmans, M. Paesmans, N. Nayer, J. P. Sculier (Brussels, Belgium)
Is there any survival benefit of surgery after neoadjuvant chemoradiotherapy and persisting pn2/3 in stage III NSCLC? V. Steger, T. Walles, B. Kosan, T. Walker, S. Veit, T. Kyriss, G. Friedel (Gerlingen, Tuebingen, Germany)
A randomised prospective trial of concurrent chemoradiotherapy (CCRT) with cisplatin and paclitaxel or docetaxel or gemcitabine in stage IIIB nonsmall cell lung cancer H. J. Ban, B. K. Yoon, S. Y. Chi, Y. S. Kwon, I. J. Oh, K. S. Kim, Y. I. Kim, S. C. Lim, Y. C. Kim, K. O. Park, J. P. Jeong, Y. C. Ko, J. G. Son, J. H. Lim, J. C. Lim (Gwangju, Suncheon, Republic Of Korea)